# Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy

> **NCT03992365** · PHASE3 · COMPLETED · sponsor: **Universal Integrated Corp.** · enrollment: 472 (actual)

## Conditions studied

- Bowel Preparation

## Interventions

- **DRUG:** Quiklean® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)
- **DRUG:** Polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride, aspartame;Bisacodyl

## Key facts

- **NCT ID:** NCT03992365
- **Lead sponsor:** Universal Integrated Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-10
- **Primary completion:** 2019-10-15
- **Final completion:** 2020-01-15
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2020-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03992365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03992365, "Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03992365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*